Newer percutaneous ventricular assist devices (pVADs) have the potential to increase the amount of circulatory support for patients undergoing percutaneous coronary intervention (PCI), but they are more expensive and are associated with increased risks compared to intraaortic balloon pumps (IABPs), according to a recent study that compared the clinical and economic impact of pVADs with IABPs for high-risk PCI patients. Read More
